Modification of the rat alloimmune response by enhancing antibodies and the role of blocking factors in the survival of renal grafts
- PMID: 1108311
- DOI: 10.1097/00007890-197511000-00003
Modification of the rat alloimmune response by enhancing antibodies and the role of blocking factors in the survival of renal grafts
Abstract
Correlation of morphological and immunological events ocurring in control and passively enhanced rat renal allograft recipients has revealed an important role for vasculitis in rejection, whereas the tempo and severity of graft lymphocyte infiltration and tubular damage was comparable in both groups during the first 5 days. Thereafter, the degree of cellular infiltration in enhanced allografts progressed and actually exceeded that in control grafts. 2-Mercaptoethanol-sensitive lymphocytotoxic antibodies were present in both groups with comparable titers and appearance times; however, the presence of a severe IgG-containing necrotizing arteritis and glomerulitis in control, but not enhanced, grafts suggests that passive enhancement protects by interfereing with the cooperative T cell-dependent inductive response. Further support for this possibility comes from the fact that the development of cytotoxic lymphocytes against donor target cells was delayed for 48 hr in the enhanced group. While controls died at days 9-11, enhanced animals entered a period of prolonged survival with stable renal function. This state of "autoenhancement" was characterized by a low degree of cell-mediated cytotoxicity and the appearance of serum factors that blocked the in vitro cellular assay. Blocking factors have a low affinity for the attacking cell population, suggesting that they are immune complexes or anti-idiotypic antibodies, and not free alloantibody of high affinity.
Similar articles
-
Cellular and humoral immunity after allogeneic renal transplantation in the rat. V. Appearance of anti-idiotypic antibody and its relationship to cellular immunity after treatment with donor spleen cells and alloantibody.Transplantation. 1976 Nov;22(5):455-66. doi: 10.1097/00007890-197611000-00008. Transplantation. 1976. PMID: 11579
-
The role of antibody in rat renal allograft rejection. I. Absence of antibody to erythrocyte-associated antigens is associated with enhanced renal allograft survival.Transplantation. 1981 May;31(5):369-75. doi: 10.1097/00007890-198105010-00013. Transplantation. 1981. PMID: 7015624
-
Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.Transplantation. 1983 Feb;35(2):121-6. Transplantation. 1983. PMID: 6338632
-
Suppression of rejection of organ allografts by alloantibody.Immunol Rev. 1980;49:93-125. doi: 10.1111/j.1600-065x.1980.tb00428.x. Immunol Rev. 1980. PMID: 6445324 Review. No abstract available.
-
Graft enhancement and antiidiotypic antibody. Lymphocytes from long-term rat renal allograft recipients have normal responsiveness in vitro.Transplant Proc. 1978 Jun;10(2):367-72. Transplant Proc. 1978. PMID: 79259 Review. No abstract available.
Cited by
-
2006 Homer W. Smith Lecture: taming T cells.J Am Soc Nephrol. 2007 Nov;18(11):2824-32. doi: 10.1681/ASN.2007070832. Epub 2007 Oct 17. J Am Soc Nephrol. 2007. PMID: 17942948 Free PMC article. No abstract available.
-
Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell.J Exp Med. 1985 Jan 1;161(1):123-33. doi: 10.1084/jem.161.1.123. J Exp Med. 1985. PMID: 3155790 Free PMC article.
-
The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement.J Exp Med. 1976 Feb 1;143(2):405-21. doi: 10.1084/jem.143.2.405. J Exp Med. 1976. PMID: 129499 Free PMC article.
-
Successful cardiac allografts in syngeneic radiation chimeras.Mol Cell Biochem. 1978 Nov 1;21(2):83-94. doi: 10.1007/BF00240279. Mol Cell Biochem. 1978. PMID: 364296
-
Transfer of specific unresponsiveness to organ allografts by thymocytes. Specific unresponsiveness by thymocyte transfer.J Exp Med. 1979 May 1;149(5):1042-55. doi: 10.1084/jem.149.5.1042. J Exp Med. 1979. PMID: 376773 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources